In spite of Inhibikase Therapeutics Inc.’s (NASDAQ:IKT) recent upswing, most analysts remain bearish.

In the latest session, Inhibikase Therapeutics Inc. (NASDAQ: IKT) closed at $0.68 down -8.75% from its previous closing price of $0.75. In other words, the price has decreased by -$0.0652 from its previous closing price. On the day, 1278098 shares were traded. IKT stock price reached its highest trading level at $0.9345 during the session, while it also had its lowest trading level at $0.6701.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".



For a deeper understanding of Inhibikase Therapeutics Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.70 and its Current Ratio is at 8.70. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 16 when Werner Milton H. bought 5,000 shares for $0.80 per share. The transaction valued at 4,000 led to the insider holds 5,335,433 shares of the business.

Werner Milton H. bought 5,000 shares of IKT for $4,880 on May 27. The President and CEO now owns 5,330,433 shares after completing the transaction at $0.98 per share. On May 20, another insider, Werner Milton H., who serves as the President and CEO of the company, bought 10,000 shares for $0.60 each. As a result, the insider paid 6,000 and bolstered with 5,325,433 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 293.26 while its Price-to-Book (P/B) ratio in mrq is 0.68.

Stock Price History:

Over the past 52 weeks, IKT has reached a high of $1.52, while it has fallen to a 52-week low of $0.44. The 50-Day Moving Average of the stock is 0.6947, while the 200-Day Moving Average is calculated to be 0.7678.

Shares Statistics:

For the past three months, IKT has traded an average of 316.83K shares per day and 611.05k over the past ten days. A total of 25.23M shares are outstanding, with a floating share count of 19.85M. Insiders hold about 21.20% of the company’s shares, while institutions hold 18.30% stake in the company. Shares short for IKT as of Jan 30, 2023 were 301.89k with a Short Ratio of 0.27M, compared to 189.78k on Dec 29, 2022. Therefore, it implies a Short% of Shares Outstanding of 1.08% and a Short% of Float of 1.33%.

Earnings Estimates

There are 0 different market analysts currently analyzing its stock. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$0.2. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.

Analysts are recommending an EPS of between -$0.74 and -$0.74 for the fiscal current year, implying an average EPS of -$0.74. EPS for the following year is -$0.68, with 1 analysts recommending between -$0.68 and -$0.68.

Revenue Estimates

A total of 1 analysts have provided revenue estimates for IKT’s current fiscal year. The highest revenue estimate was $100k, while the lowest revenue estimate was $100k, resulting in an average revenue estimate of $100k. In the same quarter a year ago, actual revenue was $3.1M, down -96.80% from the average estimate.